期刊
TOXICOLOGY LETTERS
卷 199, 期 2, 页码 123-128出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.toxlet.2010.08.013
关键词
Bisphosphonates; Macrophages; Interleukin-1beta
类别
资金
- Japan Society for the Promotion of Science [21390529]
- Grants-in-Aid for Scientific Research [21390529] Funding Source: KAKEN
Nitrogen-containing bisphosphonates (NBPs), anti-bone-resorptive drugs, exhibit inflammatory side effects (fever, jaw osteomyelitis or osteonecrosis, etc.). We previously reported that in mice: (i) a single intraperitoneal injection of alendronate (an NBP, 40 mu mol/kg or less) induces various inflammatory reactions, (ii) these effects, which are minimal in IL-1-deficient mice, can be prevented by co-administration of clodronate (a non-NBP, 40 mu mol/kg or less), and (iii) alendronate increases IL-1 beta in tissues (liver, spleen, and lung), but strangely not in blood. Here, we found the following in mice. (a) The IL-1 beta in tissues is pro-IL-1 beta. (b) Unlike LPS, alendronate induces minimal activation of caspase-1 (pro-IL-1 beta-processing enzyme). (c) The tissue pro-IL-1 beta elevations are largely absent in macrophage-depleted mice. (d) In vitro, 100 mu M alendronate directly stimulates RAW 264 cells (murine macrophage-like cells) to produce pro-IL-1 beta, and 1 mu M clodronate inhibits this effect. These results suggest that in mice: (i) the major pro-IL-1 beta-producing cells in response to alendronate are macrophages, (ii) alendronate directly stimulates them to produce pro-IL-1 beta, but the release of mature IL-1 beta is below detectable levels due to insufficient activation of caspase-1, and (iii) clodronate inhibits the pro-IL-1 beta production by acting directly on macrophages, although the in vivo mechanism may differ from the in vitro one. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据